Welcome to the Texas Coalition for Capital’s quarterly newsletter. We are a non-profit, statewide coalition of leaders supporting economic development and job creation through long-term access to capital for Texas entrepreneurs and emerging companies.

We plan to highlight Texas’ emerging investment infrastructure, recent investments, and the spectrum of funding sources available to our small businesses. Texans are pioneers, and the infrastructure we are seeing come to fruition – connecting companies and capital – is no exception.

We are a resource for promising young companies, entrepreneurs, investors, economic developers, and other stakeholders in the deal flow chain. The Texas Coalition for Capital hopes to work with you to keep Texas the most vibrant business climate in the country.

With best regards,

Craig Casselberry, President
Texas Coalition for Capital


Texas welcomes Tech Connect World Conference and Expo 2009

Key Links

Texas Emerging Technology Fund

Regional Centers of Innovation and Commercialization

Increased research collaboration between public and private sector entities exists through Regional Centers of Innovation and Commercialization (RCIC).  The eight RCICs serve as the initial point of contact for entities seeking capital from the Texas Emerging Technology Fund (TETF). The RCICs act as the regional agent for the ETF Advisory Committee to identify, evaluate, and submit promising proposals from their respective regions to the TETF Advisory Committee.

For more information, visit your local RCIC.

Texas Life Science Regional Center of Innovation
Central Texas Regional CIC
El Paso/Trans-Pecos Regional CIC
Gulf Coast Regional CIC
North Texas Regional CIC
Rio Grande Regional CIC
South Texas Regional CIC
West Texas Regional CIC

Advisory Board

Chairman, Tom Kowalski
Texas Healthcare & Bioscience Institute
President, Craig Casselberry
Quorum Public Affairs
Dan Matheson
Matheson Law Partners
Jeff Clark
Tech America
Larry Peterson
Texas Lyceum
Pike Powers
Fulbright & Jaworski
Damon Rawie
Advantage Capital Partners
Steven Anderson
West Texas Coalition for Innovation Commercialization
James Arie, Ph.D.
University ot Texas Medical Branch-Galveston
Curt Bilby
Terapio LLC
Susan Davenport
Greater Austin Chamber of Commerce/Central Texas RCIC
Guy Diedrich
Texas A&M University
York Duncan
Texas Research Park Foundation
Michael Dwyer
Azaya Therapeutics Inc.
Sloan Foster
Digital Convergence Initiative
Eric Fox
Lockheed Martin
Fernando Gonzalez
Rio Grande Valley Regional CIC
Neal Iscoe, Ph.D.
University of Texas-Office of Technology Commercialization
Martin Lindenberg
Mike Lockerd
North Texas Regional CIC
Andrew Nat
Texas Life Science Regional Center of Innovation
Beto Pallares
El Paso/Trans-Pecos Regional CIC
Jim Poage
Satai Network/South Texas Regional CIC
Brian Hermann
University of Texas Health Science Center San Antonio
Bob Prochnow
Gulf Coast Regional CIC
Terry Schpok
Akin Gump Strauss Hauer & Feld, LLP
Brent Sorrells
TECH Fort Worth
Dennis K. Stone, M.D.
University of Texas Southwestern Medical Center
Mark Ellison
Texas A&M University
Sara Patuel
The University of Texas/TechBA Program
Jacqueline Northcut

Texas’ Competitive Edge

Emerging Technology Fund key to long term economic growth
By Craig Casselberry, Tom Kowalski and Jeff Clark

We have all heard the bad news.

The National Venture Capital Association reports that venture investing in early stage businesses is down 71% over the last 12 months, and no money was raised by Texas based venture firms in the 1st quarter of 2009. Most venture funds are reserving their capital for existing portfolio companies. Small business lines of credit are not being renewed by banks seeking to preserve liquidity. As credit is tightened, companies are forced to consider layoffs to stay in business.

Historically there has been a shortage of capital available to create and grow small businesses, and the current economic climate only exacerbates the challenge.

Over the last two decades the term “economic development” has been redefined. While government efforts continue to include traditional business attraction and retention strategies, economic development today must focus on building a diverse, sustainable economy based on high-growth service and technology-based industries.

continue reading

Coalition Releases Blue Chip List of Capital Sources

The Texas Coalition for Capital is announcing the release of the most comprehensive list of capital sources in Texas.

The Blue Chip Investors list will detail public and private funding sources that are actively investing in all business sectors across the state.

“Emerging companies need consistent access to capital to ensure their success over the long term,” said Craig Casselberry, Coalition president. “This list will provide the information needed to allow these companies to access funding at all stages of their growth.”

Access to working capital often makes the difference between success and failure for small and emerging companies. Working with industry partners, investors, and public and private sector leaders, the Texas Coalition for Capital has become the premier resource in Texas for information on public and private sources of long term capital for entrepreneurs and emerging companies.

The Coalition continues to promote strong economic development and job creation in Texas by connecting companies with capital. Many small businesses are unaware of the broad spectrum of funding sources at their disposal. With the help of an impressive advisory board consisting of distinguished business leaders and entrepreneurs from across the state, the Coalition has helped secure nearly one billion dollars in funding for programs supporting young companies.

continue reading

Texas Coalition for Capital Announces New Advisory Board Members

The Texas Coalition for Capital is pleased to announce the addition of three outstanding leaders to its advisory board.

Sara Patuel, Mark Ellison, and Jacqueline Northcut join a impressive group of leaders supporting programs and policies that provide access to capital for Texas entrepreneurs and emerging companies.

“We are thrilled that these distinguished leaders agree with the Coalition’s mission,” said Craig Casselberry, Coalition president. “Their expertise will increase our organization's effectiveness as a resource for promising young Texas companies, and their experience will be most valuable in our work to keep Texas the best place to do business in America.”

The Coalition advisory board is made up of a broad cross section of leaders, including entrepreneurs, investors, industry executives, economic developers, and higher education officials.

Sara Patuel, Program Director of TechBA

Sara Patuel is a leading expert in cross-border business development between the US and key Latin American markets. As head of the University of Texas TechBA business accelerator, Sara drives initiatives which pair the university’s IC2 Institute with top-tier Mexican technology companies in a variety of industries including digital media, telecom, software, etc. The TechBA program, now touting over 30 companies, is sponsored by the Secretary of Economy of Mexico through a non-profit foundation (FUMEC). Previously, Sara occupied a senior level business development role for Fortune 50 telecom giant, MCI, where she led Hispanic partner programs and was responsible for launching multi-state programs accounting over four billion dollars in gross revenue.

Mark Ellison, Associate Vice Chancellor for Economic Development with the Texas A&M University System

Formerly he was the founding director of the Texas Emerging Technology Fund, where he oversaw more than $300,000,000 million in investment in over 40 promising Texas small businesses.

Jacqueline Northcut, President and CEO, BioHouston

Jacqueline joined BioHouston as its President and CEO in December 2002, creating an organization that is the foundation for what BioHouston has become today. BioHouston, Inc. is a non-profit, tax-exempt corporation founded by Houston-region academic/research institutions. They are leading a broad effort to establish the Houston region as a vigorous global competitor in life science and biotechnology commercialization.